Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay

Abstract excerpt

, an FDA-approved whole exome and whole transcriptome sequencing-based molecular test encompassing adult and pediatric tumor profiling, eight companion diagnostics (CDx), and additional laboratory developed test (LDT) capabilities. Patient tissue is maximized through simultaneous analysis of DNA and RNA with minimum input of 50 ng. The clinical and analytical validation presented herein demonstrates...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to GDF15 and Related Biomarkers
• Share to Macrophage Migration Inhibitory Factor
• Share to Peptidase Inhibition and Analysis